Is Next Generation Sequencing the future of blood group testing?

Area of Science:

• * Genetics and Genomics
• * Transfusion Medicine
• * Molecular Diagnostics

Background:

• * Conventional blood group phenotyping has limitations in detecting rare or novel mutations.
• * Existing high-throughput genotyping methods require prior knowledge of blood group gene polymorphisms.
• * Identifying all blood group antigens is crucial for transfusion safety and patient care.

Purpose of the Study:

• * To explore the utility of DNA sequencing for comprehensive blood group genotyping.
• * To evaluate Next Generation Sequencing (NGS) as a feasible method for blood group gene analysis.
• * To enable accurate blood group phenotype prediction in diverse populations.

Main Methods:

• * DNA sequencing of blood group genes.
• * Application of Next Generation Sequencing (NGS) technology for parallel sequencing of multiple genes and samples.
• * Bioinformatic analysis of sequencing data for polymorphism identification.

Main Results:

• * NGS technology facilitates high-throughput sequencing of blood group genes.
• * Sequencing data can accurately predict blood group phenotypes.
• * Novel and rare mutations can be identified through DNA sequencing.

Conclusions:

• * DNA sequencing, particularly using NGS, overcomes limitations of conventional blood group genotyping.
• * NGS enables comprehensive blood group determination, including rare variants.
• * This approach enhances accuracy in blood group phenotype prediction for donors and patients.